| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.9M | — | -24.5% |
| Cost of Revenue | $6.5M | — | +34.4% |
| Gross Profit | $2.4M | — | -65.9% |
| R&D Expense | $6.7M | — | +82.9% |
| SG&A Expense | $10.8M | — | +120.6% |
| Operating Income | -$17.2M | — | -456.9% |
| Pre-tax Income | -$17.1M | — | -914.1% |
| Income Tax | -$1.6M | — | -673.2% |
| Net Income | -$15.5M | — | -683.2% |
| EPS (Basic) | -$0.49 | — | -308.3% |
| EPS (Diluted) | -$0.49 | — | -308.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Inventory | $22.5M | +93.4% | — |
| Current Assets | $94.6M | -11.1% | — |
| Total Assets | $759.1M | -1.9% | — |
| Current Liabilities | $32.1M | +4.1% | — |
| Long-term Debt | $500K | -70.4% | — |
| Total Liabilities | $36.7M | +5.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$17.4M | — | -78.4% |
| Capital Expenditures | $2.1M | — | +500.9% |
| Investing Cash Flow | -$2.1M | — | -500.9% |
| Financing Cash Flow | -$640K | — | -134.8% |
| Free Cash Flow | -$19.5M | — | -92.9% |
| Stockholders' Equity | $722.4M | -2.3% | +30.7% |